Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 11.71.
Forward PE Ratio (11.71) = Close Price ($173.82) / Consensus Forward EPS ($14.85)
FORWARD PE RATIO
11.71
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-41.20%
vs the sector median at left
DaVita Inc.
Market Cap
$11.16B
Forward PE Ratio
11.71
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| DaVita Inc. (DVA) | $11.16B | 11.71 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.61 |
| Universal Health Services, Inc. (UHS)vs › | $10.73B | 7.85 |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 14.40 |
| Molina Healthcare, Inc. (MOH)vs › | $10.46B | N/A |
| Insulet Corp. (PODD)vs › | $10.26B | 22.78 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.23B | 39.42 |
| Henry Schein, Inc. (HSIC)vs › | $10.08B | 16.44 |
| Tempus AI, Inc. (TEM)vs › | $12.74B | N/A |
| Exelixis, Inc. (EXEL)vs › | $13.59B | 18.14 |
Trailing P/E
15.3
reported TTM EPS
Forward P/E
11.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $14.85 implies +30.5% EPS growth vs the reported trailing $11.38.
At today's $173.82 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $14.85 | $13.56 – $15.82 | 4 | 11.7x |
| 2027-12-31 | $17.06 | $16.82 – $17.20 | 5 | 10.2x |
| 2028-12-31 | $19.88 | $18.97 – $20.78 | 2 | 8.7x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
